Tian V. Tian

机构：Breast Cancer Research Foundation, Vall d'Hebron Institut de Recerca, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari · ORCID：0000-0002-9906-0980

发表论文 122 篇 · 总被引 1239 次 · h-index 17

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 55)
• NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy (2025 · Cancer Treatment Reviews · 被引 2)
• SAM68 is a multifunctional post-transcriptional regulator of cardiomyocyte differentiation (2026 · Nucleic Acids Research · 被引 1)
• Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis (2026 · JHEP Reports · 被引 1)
• Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomes (2025 · JHEP Reports · 被引 1)